Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Platinum × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Stomach Neoplasms 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Fallopian Tube Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Ifosfamide 27 Methotrexate 25 Doxorubicin 22 Cyclophosphamide 20 Cisplatin 19 Filgrastim 15 Etoposide 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Specimen Handling 9 Granulocyte Colony-Stimulating Factor 8 fludarabine 7 Zoledronic Acid 7 X-Rays 7 Sirolimus 7 Nivolumab 7 Neoadjuvant Therapy 7 Irinotecan 7 Drug Therapy 7 Docetaxel 7 Carboplatin 7 Biopsy 7 mifamurtide 6 apatinib 6 Phantoms, Imaging 6 Mesna 6 cabozantinib 5 Vincristine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡